Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for FLMNY and 80,000+ other tickers.
See exactly how FLMNY's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for FLMNY and 80,000+ other tickers.
Fielmann Group AG engages in vision care and audiology business in Germany, Switzerland, Austria, Spain, North America, and internationally. The company manufactures and sells visual aids mainly glasses, eyewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems and its accessories, as well as personal protective equipment. It offers its products under the fielmann, Optika Clarus, Optica & Audiologia Universitaria, Medical optica audicion, Shopko Optical, and SVS VISION brand names. The company sells its products through digital sales, retail stores, as well as…
Fielmann Group AG (FLMNY) Q4 2025 Earnings Call Transcript
Fielmann Group AG (OTCMKTS:FLMNY - Get Free Report)'s stock price dropped 12.8% during mid-day trading on Tuesday. The stock traded as low as $10.2050 and last traded at $10.2050. Approximately 570 shares changed hands during mid-day trading, an increase of 45% from the average daily volume of 393 shares. The stock had previously closed
Fielmann Group's multi-year investment cycle and international expansion have pressured margins and dividends, but set up a strong long-term growth opportunity. Recent earnings and management guidance have restored confidence, with margin recovery and dividend growth expected from 2025 onward. Personnel costs in Germany remain a headwind, but Fielmann's scale, pricing power, and operational improvements should drive market share gains.